Sleep Disturbances and Dry Eye Symptoms and Signs, Systemic Conditions, and Inflammatory Markers in the Dry Eye Assessment and Management Study
- PMID: 40365245
- PMCID: PMC12070294
- DOI: 10.1097/coa.0000000000000048
Sleep Disturbances and Dry Eye Symptoms and Signs, Systemic Conditions, and Inflammatory Markers in the Dry Eye Assessment and Management Study
Abstract
Purpose: To investigate the association between sleep disturbances, dry eye disease (DED) severity, and DED risk factors.
Methods: We conducted a secondary analysis of the Dry Eye Assessment and Management (DREAM) study, a randomized trial of 535 patients with moderate-to-severe DED. Participants self-reported sleep disturbances at baseline. DED symptoms were assessed using the Ocular Surface Disease Index (OSDI) and Brief Ocular Discomfort Index (BODI). DED signs were assessed using tear film break-up time, Schirmer test, corneal and conjunctival staining, tear osmolarity, and meibomian gland dysfunction assessment. Immune cells were assessed using conjunctival impression cytology. Outcomes were compared between participants with ongoing and no history of sleep disturbances, adjusting for confounders.
Results: Mean age was 58 years, with 81% female participants. Ongoing sleep disturbances (n=113) were significantly associated with older age (mean 60.5 vs. 57.4; p=0.03), smoking (39.8% vs. 28.7%; p=0.02), and DED treatment usage. Systemic conditions associated with sleep disturbances included thyroid dysfunction (26.5% vs.15.7% p=0.007), irritable bowel (18.6% vs. 5.4%; p<.0001), osteoarthritis (38.9% vs. 21.6%; p=0.0007), and depression (30.1% vs. 11.5%; p<.0001). Sleep disturbances were associated with lower conjunctival staining scores (2.46 vs. 2.77; p=0.03) and higher concentrations of dendritic cells in ocular surface white blood cells (12.0% vs. 8.1%; p=0.01).
Conclusions: Sleep disturbances were associated with older age, smoking history, systemic diseases, and higher dendritic cell concentration among patients with moderate-to-severe DED. These findings support further investigation of sleep disturbances as a comorbidity of patients with DED. Additional research is needed to understand the mechanisms behind this relationship.
Keywords: dry eye disease; dry eye risk factors; inflammatory markers; sleep disturbances.
Conflict of interest statement
Conflict of interest statement: None to disclose.
Similar articles
-
Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.Ophthalmology. 2021 Oct;128(10):1384-1392. doi: 10.1016/j.ophtha.2021.03.030. Epub 2021 Mar 27. Ophthalmology. 2021. PMID: 33785415 Free PMC article. Clinical Trial.
-
Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.JAMA Ophthalmol. 2022 Apr 1;140(4):392-399. doi: 10.1001/jamaophthalmol.2022.0140. JAMA Ophthalmol. 2022. PMID: 35266971 Free PMC article. Clinical Trial.
-
Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.Ophthalmol Sci. 2023 Jan 12;3(2):100270. doi: 10.1016/j.xops.2023.100270. eCollection 2023 Jun. Ophthalmol Sci. 2023. PMID: 36846104 Free PMC article.
-
LipiFlow for the treatment of dry eye disease.Cochrane Database Syst Rev. 2024 Feb 5;2(2):CD015448. doi: 10.1002/14651858.CD015448.pub2. Cochrane Database Syst Rev. 2024. PMID: 38314898 Free PMC article.
-
Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.Ophthalmol Ther. 2020 Dec;9(4):877-888. doi: 10.1007/s40123-020-00308-z. Epub 2020 Oct 22. Ophthalmol Ther. 2020. PMID: 33090327 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources